Plaintiff Bid To Disband Baycol MDL Nixed
A federal judge has tossed a putative class action from the multidistrict litigation over Bayer's anti-cholesterol drug Baycol after granting the drugmaker's request for summary judgment and denying the plaintiffs' motion...To view the full article, register now.
Already a subscriber? Click here to view full article